Peptide design to control protein-protein interactions.

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Computational Biology

Background:

• Targeting protein-protein interactions (PPIs) is vital in biological sciences for controlling cellular processes.
• Advances in cryo-electron microscopy (cryo-EM) and protein structure prediction tools (e.g., AlphaFold, RosettaFold) have accelerated interest in PPI modulation.
• Peptide design serves as a foundational strategy for developing molecules that inhibit or stabilize protein interactions.

Purpose of the Study:

• To provide a tutorial review on the process of peptide design for modulating protein-protein interactions.
• To highlight methods for selecting initial peptide sequences, with or without structural data.
• To discuss strategies for optimizing peptide affinity and drug-like properties.

Main Methods:

• Selection of initial peptide sequences based on available structural information or de novo design.
• Analysis of key residues within the peptide sequence to guide optimization.
• Strategies for enhancing ligand efficiency, affinity, and cell permeability of peptides.

Main Results:

• Demonstration of a systematic approach to peptide design for PPI targeting.
• Identification of methods to improve peptide efficacy and drug-likeness.
• Guidance on leveraging structural and sequence information for rational peptide optimization.

Conclusions:

• Peptide design is a powerful starting point for developing therapeutics that target protein-protein interactions.
• Optimization of sequence, ligand efficiency, and physicochemical properties is key to successful peptide-based drug discovery.
• Further modifications can enhance peptide affinity and cell permeability, improving their potential as pharmaceuticals.